You are here

RP-A501

Rocket boosted as FDA alignment on pivotal gene therapy trial design sends stock skyward

Rocket boosted as FDA alignment on pivotal gene therapy trial design sends stock skyward

Fierce Biotech

Rocket Pharmaceuticals

clinical trials

Flag link:

New pediatric data shoot Rocket's gene therapy toward phase 2, leaving behind FDA concerns

New pediatric data shoot Rocket's gene therapy toward phase 2, leaving behind FDA concerns

Fierce Biotech

Rocket Pharmaceuticals

clinical trials

Flag link:

Rocket begins patient dosing in phase 1 trial of RP-A501 in Danon disease

Rocket begins patient dosing in phase 1 trial of RP-A501 in Danon disease

Pharmaceutical Business Review

Rocket Pharmaceuticals

Flag link:

Rocket Pharmaceuticals Releases Preclinical Data for First Investigational Gene Therapy Program for Rare Heart Disorder

Rocket Pharmaceuticals Releases Preclinical Data for First Investigational Gene Therapy Program for Rare Heart Disorder

CP Wire

Rocket Pharmaceuticals

Flag link:

Rocket Pharmaceuticals Releases Preclinical Data for First Investigational Gene Therapy Program for Rare Heart Disorder

Rocket Pharmaceuticals

Flag link: